FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054016650> ?p ?o ?g. }

• W2054016650 endingPage "236" @default.
• W2054016650 startingPage "232" @default.
• W2054016650 abstract "Advanced glycation end products (AGEs) are thought to play a major pathogenic role in diabetic retinopathy. The most important AGE is unknown, but as increased serum methylglyoxal-derived hydroimidazolone has been demonstrated in patients with type 2 diabetes mellitus, the aim of the present study was to elucidate possible associations between serum levels of hydroimidazolone and retinopathy in patients with type 2 diabetes mellitus. We recruited 227 patients with type 2 diabetes mellitus and retinopathy ranging from none to proliferative. Level of retinopathy was determined from 7 standard field stereo photographs per eye according to the Early Treatment Diabetic Retinopathy Study. The patients were 66 +/- 11 years old, with a known diabetes duration of 14 +/- 9 years. Serum levels of hydroimidazolone were determined with a competitive immunoassay. Serum levels of hydroimidazolone were increased in nonproliferative (median, 4.50 U/mL; interquartile range, 3.69-5.77 U/mL) and proliferative retinopathy (median, 4.88 U/mL; interquartile range, 3.70-6.52 U/mL) compared with patients without retinopathy (median, 4.02 U/mL; interquartile range, 3.47-4.88 U/mL) (P = .008 and .002, respectively). There was no association between hydroimidazolone and hemoglobin A1c (r = 0.04, P = .57). In addition, patients with proliferative retinopathy and a relatively short known duration of diabetes, that is, less than the median of 14 years, had increased serum levels of hydroimidazolone (median, 6.91 U/mL; interquartile range, 4.70-8.91 U/mL) compared with those with nonproliferative retinopathy (median, 4.34; interquartile range, 3.86-5.53U/mL, P = .015). Serum levels of hydroimidazolone are increased in type 2 diabetic patients with retinopathy. This association is independent of hitherto known associated factors, such as hemoglobin A1c." @default.
• W2054016650 created "2016-06-24" @default.
• W2054016650 creator A5029964586 @default.
• W2054016650 creator A5033854655 @default.
• W2054016650 creator A5071845653 @default.
• W2054016650 creator A5073390769 @default.
• W2054016650 creator A5074326494 @default.
• W2054016650 creator A5084278671 @default.
• W2054016650 creator A5085379404 @default.
• W2054016650 creator A5090595357 @default.
• W2054016650 date "2006-02-01" @default.
• W2054016650 modified "2023-10-18" @default.
• W2054016650 title "Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus" @default.
• W2054016650 cites W1965146473 @default.
• W2054016650 cites W1970789531 @default.
• W2054016650 cites W1994051814 @default.
• W2054016650 cites W1997259202 @default.
• W2054016650 cites W2000663727 @default.
• W2054016650 cites W2005767645 @default.
• W2054016650 cites W2019226618 @default.
• W2054016650 cites W2020552955 @default.
• W2054016650 cites W2036871339 @default.
• W2054016650 cites W2043243208 @default.
• W2054016650 cites W2053615344 @default.
• W2054016650 cites W2057683168 @default.
• W2054016650 cites W2066779642 @default.
• W2054016650 cites W2074214994 @default.
• W2054016650 cites W2078540617 @default.
• W2054016650 cites W2086321305 @default.
• W2054016650 cites W2142007424 @default.
• W2054016650 cites W2144776559 @default.
• W2054016650 cites W4244248663 @default.
• W2054016650 cites W4247237039 @default.
• W2054016650 cites W4256166634 @default.
• W2054016650 doi "https://doi.org/10.1016/j.metabol.2005.08.017" @default.
• W2054016650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16423631" @default.
• W2054016650 hasPublicationYear "2006" @default.
• W2054016650 type Work @default.
• W2054016650 sameAs 2054016650 @default.
• W2054016650 citedByCount "109" @default.
• W2054016650 countsByYear W20540166502012 @default.
• W2054016650 countsByYear W20540166502013 @default.
• W2054016650 countsByYear W20540166502014 @default.
• W2054016650 countsByYear W20540166502015 @default.
• W2054016650 countsByYear W20540166502016 @default.
• W2054016650 countsByYear W20540166502017 @default.
• W2054016650 countsByYear W20540166502018 @default.
• W2054016650 countsByYear W20540166502019 @default.
• W2054016650 countsByYear W20540166502020 @default.
• W2054016650 countsByYear W20540166502021 @default.
• W2054016650 countsByYear W20540166502022 @default.
• W2054016650 countsByYear W20540166502023 @default.
• W2054016650 crossrefType "journal-article" @default.
• W2054016650 hasAuthorship W2054016650A5029964586 @default.
• W2054016650 hasAuthorship W2054016650A5033854655 @default.
• W2054016650 hasAuthorship W2054016650A5071845653 @default.
• W2054016650 hasAuthorship W2054016650A5073390769 @default.
• W2054016650 hasAuthorship W2054016650A5074326494 @default.
• W2054016650 hasAuthorship W2054016650A5084278671 @default.
• W2054016650 hasAuthorship W2054016650A5085379404 @default.
• W2054016650 hasAuthorship W2054016650A5090595357 @default.
• W2054016650 hasBestOaLocation W20540166502 @default.
• W2054016650 hasConcept C118487528 @default.
• W2054016650 hasConcept C119060515 @default.
• W2054016650 hasConcept C126322002 @default.
• W2054016650 hasConcept C134018914 @default.
• W2054016650 hasConcept C147990577 @default.
• W2054016650 hasConcept C181199279 @default.
• W2054016650 hasConcept C185592680 @default.
• W2054016650 hasConcept C2778313320 @default.
• W2054016650 hasConcept C2778592357 @default.
• W2054016650 hasConcept C2779829184 @default.
• W2054016650 hasConcept C2910068830 @default.
• W2054016650 hasConcept C55493867 @default.
• W2054016650 hasConcept C555293320 @default.
• W2054016650 hasConcept C71924100 @default.
• W2054016650 hasConcept C90924648 @default.
• W2054016650 hasConceptScore W2054016650C118487528 @default.
• W2054016650 hasConceptScore W2054016650C119060515 @default.
• W2054016650 hasConceptScore W2054016650C126322002 @default.
• W2054016650 hasConceptScore W2054016650C134018914 @default.
• W2054016650 hasConceptScore W2054016650C147990577 @default.
• W2054016650 hasConceptScore W2054016650C181199279 @default.
• W2054016650 hasConceptScore W2054016650C185592680 @default.
• W2054016650 hasConceptScore W2054016650C2778313320 @default.
• W2054016650 hasConceptScore W2054016650C2778592357 @default.
• W2054016650 hasConceptScore W2054016650C2779829184 @default.
• W2054016650 hasConceptScore W2054016650C2910068830 @default.
• W2054016650 hasConceptScore W2054016650C55493867 @default.
• W2054016650 hasConceptScore W2054016650C555293320 @default.
• W2054016650 hasConceptScore W2054016650C71924100 @default.
• W2054016650 hasConceptScore W2054016650C90924648 @default.
• W2054016650 hasIssue "2" @default.
• W2054016650 hasLocation W20540166501 @default.
• W2054016650 hasLocation W20540166502 @default.
• W2054016650 hasLocation W20540166503 @default.
• W2054016650 hasOpenAccess W2054016650 @default.
• W2054016650 hasPrimaryLocation W20540166501 @default.

• next